Drug-loaded exosomal preparations from different cell types exhibit distinctive loading capability, yield, and antitumor efficacies: a comparative analysis

References

• RoserMRitchieHhomepage on the InternetCancer2018 Available from: https://ourworldindata.org/cancerAccessed August 22, 2018
   Google Scholar
• ChakrabortySRahmanTThe difficulties in cancer treatmentEcancermedicalscience20126ed1624883085
   PubMedGoogle Scholar
• VadlapatlaRKVadlapudiADPalDMitraAKMechanisms of drug resistance in cancer chemotherapy: coordinated role and regulation of efflux transporters and metabolizing enzymesCurr Pharm Des201319407126714023829373
   PubMed Web of Science ®Google Scholar
• HeoDNYangDHMoonHJGold nanoparticles surface-functionalized with paclitaxel drug and biotin receptor as theranostic agents for cancer therapyBiomaterials201233385686622036101
   PubMed Web of Science ®Google Scholar
• ZhuSHongMZhangLTangGJiangYPeiYPEGylated PAMAM dendrimer-doxorubicin conjugates: in vitro evaluation and in vivo tumor accumulationPharm Res201027116117419862607
   PubMed Web of Science ®Google Scholar
• GabizonAAPegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapyCancer Invest200119442443611405181
   PubMed Web of Science ®Google Scholar
• SongJZhouJDuanHSelf-assembled plasmonic vesicles of SERS-encoded amphiphilic gold nanoparticles for cancer cell targeting and traceable intracellular drug deliveryJ Am Chem Soc201213432134581346922831389
   PubMed Web of Science ®Google Scholar
• SunCLeeJSZhangMMagnetic nanoparticles in MR imaging and drug deliveryAdv Drug Deliv Rev200860111252126518558452
   PubMed Web of Science ®Google Scholar
• MasoodFPolymeric nanoparticles for targeted drug delivery system for cancer therapyMater Sci Eng C201660569578
   PubMed Web of Science ®Google Scholar
• JohnsenKBGudbergssonJMSkovMNPilgaardLMoosTDurouxMA comprehensive overview of exosomes as drug delivery vehicles – endogenous nanocarriers for targeted cancer therapyBiochim Biophys Acta1846201417587
   Google Scholar
• LeeYKChoiEJWebsterTJKimSHKhangDEffect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicityInt J Nanomedicine2015109711325565807
   PubMed Web of Science ®Google Scholar
• ThéryCZitvogelLAmigorenaSExosomes: composition, biogenesis and functionNat Rev Immunol20022856957912154376
   PubMed Web of Science ®Google Scholar
• KalluriRThe biology and function of exosomes in cancerJ Clin Invest201612641208121527035812
   PubMed Web of Science ®Google Scholar
• FévrierBRaposoGExosomes: endosomal-derived vesicles shipping extracellular messagesCurr Opin Cell Biol200416441542115261674
   PubMed Web of Science ®Google Scholar
• ThakurBKZhangHBeckerADouble-stranded DNA in exosomes: a novel biomarker in cancer detectionCell Res201424676676924710597
   PubMed Web of Science ®Google Scholar
• JanasTJanasMMSapońKJanasTMechanisms of RNA loading into exosomesFEBS Lett2015589131391139825937124
   PubMed Web of Science ®Google Scholar
• BangCThumTExosomes: new players in cell-cell communicationInt J Biochem Cell Biol201244112060206422903023
   PubMed Web of Science ®Google Scholar
• WhitesideTLExosomes carrying immunoinhibitory proteins and their role in cancerClin Exp Immunol2017189325926728369805
   PubMed Web of Science ®Google Scholar
• LaiRCYeoRWTanKHLimSKExosomes for drug delivery – a novel application for the mesenchymal stem cellBiotechnol Adv201331554355122959595
   PubMed Web of Science ®Google Scholar
• MckelveyKJPowellKLAshtonAWMorrisJMMccrackenSAExosomes: mechanisms of uptakeJ Circ Biomark20154728936243
   PubMedGoogle Scholar
• KimMSHaneyMJZhaoYEngineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluationsNanomedicine201814119520428982587
   PubMed Web of Science ®Google Scholar
• PascucciLCoccèVBonomiAPaclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug deliveryJ Control Release201419226227025084218
   PubMed Web of Science ®Google Scholar
• SunDZhuangXXiangXA novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomesMol Ther20101891606161420571541
   PubMed Web of Science ®Google Scholar
• TianTZhangHXHeCPSurface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapyBiomaterials201815013714929040874
   PubMed Web of Science ®Google Scholar
• SaariHLázaro-IbáñezEViitalaTVuorimaa-LaukkanenESiljanderPYliperttulaMMicrovesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cellsJ Control Release2015220Pt B72773726390807
   PubMed Web of Science ®Google Scholar
• PatelGKKhanMABhardwajAExosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCKBr J Cancer2017116560961928152544
   PubMed Web of Science ®Google Scholar
• SzczepanskiMJSzajnikMWelshAWhitesideTLBoyiadzisMBlast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor-1Haematologica20119691302130921606166
   PubMed Web of Science ®Google Scholar
• MaiaJCajaSStrano MoraesMCCoutoNCosta-SilvaBExosome-based cell-cell communication in the tumor microenvironmentFront Cell Dev Biol20186181829515996
   PubMedGoogle Scholar
• PattonMCZubairHPatelGKSinghSSinghAPAbstract 2799: exosomes from hypoxic pancreatic cancer cells confer resistance to subsequent hypoxia insultCancer Res20167614 Suppl2799
   Google Scholar
• KingHWMichaelMZGleadleJMHypoxic enhancement of exosome release by breast cancer cellsBMC Cancer201212142122998595
   PubMed Web of Science ®Google Scholar
• XiaoXYuSLiSExosomes: decreased sensitivity of lung cancer A549 cells to cisplatinPLoS One201492e8953424586853
   PubMed Web of Science ®Google Scholar
• HessvikNPLlorenteACurrent knowledge on exosome biogenesis and releaseCell Mol Life Sci201875219320828733901
   PubMed Web of Science ®Google Scholar
• LeeCMTannockIFInhibition of endosomal sequestration of basic anticancer drugs: influence on cytotoxicity and tissue penetrationBr J Cancer200694686386916495919
   PubMedGoogle Scholar
• SafaeiRLarsonBJChengTCAbnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cellsMol Cancer Ther20054101595160416227410
   PubMed Web of Science ®Google Scholar
• LiTWangYNKhokhlovaTDPulsed high-intensity focused ultrasound enhances delivery of doxorubicin in a preclinical model of pancreatic cancerCancer Res201575183738374626216548
   PubMed Web of Science ®Google Scholar
• ArachchigeMPLahaSSNaikARLewisKTNaikRJenaBPFunctionalized nanoparticles enable tracking the rapid entry and release of doxorubicin in human pancreatic cancer cellsMicron201792253127846432
   PubMedGoogle Scholar
• XuXZhaoYZhangMInhibition of autophagy by deguelin sensitizes pancreatic cancer cells to doxorubicinInt J Mol Sci2017182370
   PubMed Web of Science ®Google Scholar
• BorstPCancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?Open Biol20122512006622724067
   PubMedGoogle Scholar
• GottesmanMMMechanisms of cancer drug resistanceAnnu Rev Med200253161562711818492
   PubMed Web of Science ®Google Scholar
• DeanMFojoTBatesSTumour stem cells and drug resistanceNat Rev Cancer20055427528415803154
   PubMed Web of Science ®Google Scholar
• TacarOSriamornsakPDassCRDoxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systemsJ Pharm Pharmacol201365215717023278683
   PubMed Web of Science ®Google Scholar
• YangXHSladekTLLiuXButlerBRFroelichCJThorADReconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin-and etoposide-induced apoptosisCancer Res200161134835411196185
   PubMed Web of Science ®Google Scholar
• DeshmukhSKSrivastavaSKZubairHResistin potentiates chemoresistance and stemness of breast cancer cells: implications for racially disparate therapeutic outcomesCancer Lett2017396212928302531
   PubMedGoogle Scholar
• MengHLiongMXiaTEngineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell lineACS Nano2010484539455020731437
   PubMed Web of Science ®Google Scholar
• GorenDHorowitzATTzemachDTarshishMZalipskySGabizonANuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pumpClin Cancer Res2000651949195710815920
   PubMed Web of Science ®Google Scholar
• RivaBBelliniMCorviEImpact of the strategy adopted for drug loading in nonporous silica nanoparticles on the drug release and cytotoxic activityJ Colloid Interface Sci2018519182629477896
   PubMedGoogle Scholar
• WangFWangYCDouSXiongMHSunTMWangJDoxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cellsACS Nano2011553679369221462992
   PubMed Web of Science ®Google Scholar
• TicknerJAUrquhartAJStephensonS-ARichardDJO’ByrneKJFunctions and therapeutic roles of exosomes in cancerFront Oncol201441012724904836
   PubMedGoogle Scholar
• ChenWJiangJXiaWHuangJTumor-related exosomes contribute to tumor-promoting microenvironment: an immunological perspectiveJ Immunol Res2017201711110
   Google Scholar
• HannafonBNDingWQIntercellular communication by exosome-derived microRNAs in cancerInt J Mol Sci2013147142401426923839094
   PubMed Web of Science ®Google Scholar
• LehmannBDPaineMSBrooksAMSenescence-associated exosome release from human prostate cancer cellsCancer Res200868197864787118829542
   PubMed Web of Science ®Google Scholar
• LugeaAWaldronRTExosome-mediated intercellular communication between stellate cells and cancer cells in pancreatic ductal adenocarcinomaPancreas20174611427977625
   PubMedGoogle Scholar
• DeshmukhSKTyagiNKhanMAGemcitabine treatment promotes immunosuppressive microenvironment in pancreatic tumors by supporting the infiltration, growth, and polarization of macrophagesSci Rep2018811200030097594
   PubMedGoogle Scholar
• ChengLWangYHuangLExosomes from M1-polarized macrophages potentiate the cancer vaccine by creating a pro-inflammatory microenvironment in the lymph nodeMol Ther20172571665167528284981
   PubMed Web of Science ®Google Scholar